Complications after lung radiofrequency ablation: Risk factors for lung inflammation

British Journal of Radiology

Volumn 81, Issue 963, 2008, Pages 244-249

  Nomura, Miwako ^a   Yamakado, K ^a   Nomoto, Y ^a   Nakatsuka, A ^a   Ii, N ^a   Takaki, H ^a   Yamashita, Y ^a   Takeda, K ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LUNG SURGERY; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD REVIEW; MORBIDITY; MULTIVARIATE ANALYSIS; PLEURISY; PNEUMONIA; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SURGICAL MORTALITY; SURGICAL PATIENT; TUMOR VOLUME; UNIVARIATE ANALYSIS; AGED; CATHETER ABLATION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CATHETER ABLATION; CHILD; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40749108111     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/84269673     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Sullivan V, Tran T, Holmstrom A, Kuskowski M, Koh P, Rubins JB, et al. Advanced age does not exclude lobectomy for non-small cell lung carcinoma. Chest 2005;128:2671-6.
3. Jensen AD, Munter MW, Bischoff H, Haselmann R, Timke C, Krempien R, et al. Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518). BMC Cancer 2006;6:122.
4. Rossi S, Di SM, Buscarini E, Quaretti P, Garbagnati F, Squassante L, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-68.
5. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-8.
6. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000;174:57-9.
7. Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15:463-70.
8. Steinke K, Sewell PE, Dupuy D, Lencioni R, Helmberger T, Kee ST, et al. Pulmonary radiofrequency ablation - an international study survey. Anticancer Res 2004;24:339-43.
9. Zubrod CG, Schneiderman M, Frei E III, Brindley C, Gold GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative trial of nitrogen mustard and trimethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
10. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD III, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vase Interv Radiol 2005;16:765-78.
11. Aviram G, Yu E, Tai P, Lefcoe MS. Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer. Can Assoc Radiol J 2001;52:385-91.
12. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002;35:103-9.
13. Sano Y, Kanazawa S, Gobara H, Mukai T, Hiraki T, Hase S, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007;109:1397-405.
14. Rossi S, Dore R, Cascina A, Vespro V, Garbagnati F, Rosa L, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006;27:556-63.
15. Sakamoto S, Homma S, Kawabata M, Kono T, Seki K, Nakata K, et al. [Fatal acute exacerbation of idiopathic pulmonary fibrosis/usual interstitial pneumonia initially in the right lung after surgery lobectomy for left lung cancer]. Nihon Kokyuki Gakkai Zasshi 2004;42:760-6.
16. Yuksel M, Ozyurtkan MO, Bostanci K, Ahiskali R, Kodalli N. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg 2006;82:336-8.
17. Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 2001;17:175-9.
18. Hoshikawa Y, Kondo T. [Perioperative lung injury: acute exacerbation of idiopathic pulmonary fibrosis and acute interstitial pneumonia after pulmonary resection]. Nippon Geka Gakkai Zasshi 2004;105:757-62.
19. Tokiya R, Hiratsuka J, Yoshida K, Imai S, Kajihara Y, Imajo Y. Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy. Int J Clin Oncol 2004;9:498-502.
20. Matsuno Y, Satoh H, Ishikawa H, Kodama T, Ohtsuka M, Sekizawa K. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy. Med Oncol 2006;23:75-82.
21. Goto K, Kodama T, Sekine I, Kakinuma R, Kubota K, Hojo F, et al. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis. Lung Cancer 2001;34:141-8.
22. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002;12:26-33.
23. Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738-45.
24. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.